Navellier & Associates Inc. acquired a new position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 7,727 shares of the company’s stock, valued at approximately $478,000. Other hedge funds also recently bought and sold […]
Nordea Investment Management AB trimmed its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 0.1% during the third quarter, Holdings Channel.com reports. The fund owned 338,443 shares of the company’s stock after selling 349 shares during the quarter. Nordea Investment Management AB’s holdings in Amphastar Pharmaceuticals were worth $15,700,000 as of […]
Shariaportfolio Inc. acquired a new position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 12,505 shares of the company’s stock, valued at approximately $575,000. Other institutional investors and hedge funds […]
Guidance Capital Inc. purchased a new stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 6,885 shares of the company’s stock, valued at approximately $377,000. Other hedge funds and other institutional investors […]
Renaissance Technologies LLC cut its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 0.8% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 492,583 shares of the company’s stock after selling 4,217 shares during the period. Renaissance Technologies LLC […]